Skip to content

Acmella Oleracea in the Analgesia of the Digital Rectal Examination

Acmella Oleracea in the Analgesia of the Digital Rectal Examination

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05141864
Enrollment
150
Registered
2021-12-02
Start date
2021-03-05
Completion date
2021-11-05
Last updated
2021-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia in the Digital Rectal Examination

Keywords

Prostatic neoplasms, Digital Rectal Examination, Phytotherapy, Pain, Analgesia, Spilanthes oleracea

Brief summary

The aim of the study is to develop an herbal gel based on Acmella oleracea and do a comparative analysis to evaluate the intensity of pain during the digital rectal examination comparing to lidocaine gel group and ultrasound gel group.

Detailed description

The aim of the study is to develop an herbal gel based on Acmella oleracea and do a comparative analysis to evaluate the intensity of pain during the digital rectal examination comparing to lidocaine gel group and ultrasound gel group. We are conducting a randomized, controlled, single-blind clinical trial of man undergoing to digital rectal examination, with 150 participants. Will be recruit at the Urologic Clinic of the Samuel Libânio Clinical Hospital and Urologic Clinic CISAMESP in Pouso Alegre. Participants divided into three groups, A. oleracea gel group, lidocaine gel group and ultrasound gel group. The digital rectal examination always performed by the same doctor, on the same position. A visual analogue scale (VAS) will be the standard method to evaluate the pain levels. The VAS will be explained to all patients, 0 = no pain and 10 = the most severe pain.

Interventions

BIOLOGICALAcmella oleracea gel

Study group will use Acmella oleracea gel during the digital rectal examination.

DRUGLidocaine 2 % Topical Cream

Control group will use lidocaine 2% gel during the digital rectal examination.

Control group will use ultrasound gel during the digital rectal examination.

Sponsors

Universidade do Vale do Sapucai
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
45 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Male patients * Patients to agree to participate in the study

Exclusion criteria

* Diabetic, chronic kidney disease, with urogenital infections, using an indwelling urinary catheter, with history of anorectal diseases or surgeries, psychiatric patients and who refused to participate in the research

Design outcomes

Primary

MeasureTime frameDescription
Evaluate the pain1 day (After the digital rectal examination)A visual analogue scale (VAS) will be the standard method to evaluate the pain levels. The VAS will be explained to all patients, 0 = no pain and 10 = the most severe pain.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026